Clinical Study

Effects of a Multispecies Probiotic Mixture on Glycemic Control and Inflammatory Status in Women with Gestational Diabetes: A Randomized Controlled Clinical Trial

Table 2

Dietary intakes of the intention-to-treat participants at baseline and at the end of the study.

VariablesPeriodProbiotic group ()Control group () value

Energy (kcal/d)Initial2331 ± 1322382 ± 1490.22
End2288 ± 1172310 ± 1690.13

Carbohydrate (g/d)Initial310.8 ± 38.8318.1 ± 39.10.23
End302.4 ± 38.2309.4 ± 39.80.29

Protein (g/d)Initial79.3 ± 11.480.4 ± 13.40.22
End76.2 ± 14.278.7 ± 13.90.19

Total fat (g/d)Initial77.2 ± 12.679.6 ± 8.10.34
End73.3 ± 13.274.1 ± 10.80.41

Dietary fiber (g/d)Initial13.8 ± 3.214.6 ± 3.80.25
End13.1 ± 4.413.6 ± 3.90.29

PUFA (g/d)Initial20.9 ± 4.521.8 ± 3.90.36
End25.1 ± 5.723.7 ± 6.10.19

MUFA (g/d)Initial21.9 ± 6.223.8 ± 5.80.48
End19.8 ± 8.820.7 ± 6.20.56

Zinc (mg/d)Initial11.8 ± 3.19.8 ± 2.10.32
End10.8 ± 2.610.4 ± 3.20.47

Copper (mg/d)Initial1.39 ± 0.31.42 ± 0.50.29
End1.49 ± 0.51.55 ± 0.70.31

Data are presented as mean (SD); SFA: saturated fatty acid; PUFA: polyunsaturated fatty acid; MUFA: monounsaturated fatty acid; : obtained from Student’s -test.